Clinical Characteristics and Thrombophilia Associated Gene Variants in Egyptians with Unprovoked Venous Thromboembolism: Three Centers Experience

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2024 Sep 26

PMID 39325233

Authors

Alaa Efat

Sabry Shoeib

Abdelmonem Ahmed Abdelmonem

Medhat Maher Elamawy

Hiam Abdallah Eleleimy

Reda Abdelatif Ibrahem

Suzan M Elmorshedy

Mona Mahrous Abdelaty

Affiliations

Soon will be listed here.

Abstract

Background: Thrombophilias are characterized by excessive venous and arterial thrombosis at regular or unusual sites. It may result from inherited, acquired, or a combination. Hereditary thrombophilia (HT) is detected in 30-40% of patients with thromboembolism. Venous/arterial thrombosis is considered a multifactorial disorder, some patients may have more than one risk factor which may be transient or permanent.

Objectives: Assess the clinical characteristics of patients with unprovoked thromboembolic events and the role of inherited thrombophilia as a causative or additive risk factor.

Methods: 210 consecutive adult patients with unprovoked thromboembolic events were reviewed in hematology units at three tertiary Egyptian centers between September 2022 and September 2023. The diagnosis of thromboembolic events was confirmed by clinical and radiological findings. Laboratory screening for thrombophilia-associated.

Results: Among our patients, 53(25.2%) patients presented with isolated DVT, followed by portal vein thrombosis, 32(15.2%) had a pulmonary embolism, and sagittal sinus thrombosis was developed in 23(10.9%) patients.

Conclusion: Younger people who experience spontaneous thromboembolism run the chance of having hereditary thrombophilia; the more mutations discovered, the higher the risk of thrombosis; the lower leg and deep vein thrombosis were the most common sites. Lastly, MTHFR C677T was the most common polymorphism in Egyptians, detected in almost half of the cases.

References

Dicks A, Moussallem E, Stanbro M, Walls J, Gandhi S, Gray B . A Comprehensive Review of Risk Factors and Thrombophilia Evaluation in Venous Thromboembolism. J Clin Med. 2024; 13(2). PMC: 10816375. DOI: 10.3390/jcm13020362. View

Tang L, Hu Y . Ethnic diversity in the genetics of venous thromboembolism. Thromb Haemost. 2015; 114(5):901-9. DOI: 10.1160/TH15-04-0330. View

Dautaj A, Krasi G, Bushati V, Precone V, Gheza M, Fioretti F . Hereditary thrombophilia. Acta Biomed. 2019; 90(10-S):44-46. PMC: 7233636. DOI: 10.23750/abm.v90i10-S.8758. View

Stevens S, Woller S, Bauer K, Kasthuri R, Cushman M, Streiff M . Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016; 41(1):154-64. PMC: 4715840. DOI: 10.1007/s11239-015-1316-1. View

Goodwin A, Adcock D . Thrombophilia Testing and Venous Thrombosis. N Engl J Med. 2017; 377(23):2297-8. DOI: 10.1056/NEJMc1713797. View

Miyata T, Sato Y, Ishikawa J, Okada H, Takeshita S, Sakata T . Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis. Thromb Res. 2008; 124(1):14-8. DOI: 10.1016/j.thromres.2008.08.020. View

Weingarz L, Schwonberg J, Schindewolf M, Hecking C, Wolf Z, Erbe M . Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry. Br J Haematol. 2013; 163(5):655-65. DOI: 10.1111/bjh.12575. View

Lee S, Kim E, Kim M, Shin S, Chang H, Jang S . The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms. PLoS One. 2017; 12(10):e0185785. PMC: 5645010. DOI: 10.1371/journal.pone.0185785. View

Bezgin T, Kaymaz C, Akbal O, Yilmaz F, Tokgoz H, Ozdemir N . Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study. Clin Appl Thromb Hemost. 2016; 24(1):100-106. PMC: 6714624. DOI: 10.1177/1076029616672585. View

10.

Meyer G, Emmerich J, Helley D, Arnaud E, Nicaud V, Alhenc-Gelas M . Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med. 2001; 110(1):12-5. DOI: 10.1016/s0002-9343(00)00653-7. View

11.

Arsov T, Miladinova D, Spiroski M . Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels. Croat Med J. 2006; 47(3):433-9. PMC: 2080416. View

12.

Olivo Freites C, Naymagon L . The utility of hereditary thrombophilia testing among patients with unprovoked venous thromboembolism. Int J Lab Hematol. 2021; 44(2):393-398. DOI: 10.1111/ijlh.13752. View

13.

Bouaziz-Borgi L, Almawi W, Mtiraoui N, Nsiri B, Keleshian S, Kreidy R . Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon. Am J Hematol. 2006; 81(8):641-3. DOI: 10.1002/ajh.20582. View

14.

Lijfering W, Middeldorp S, Veeger N, Hamulyak K, Prins M, Buller H . Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation. 2010; 121(15):1706-12. DOI: 10.1161/CIRCULATIONAHA.109.906347. View

15.

El-Khawaga O, Al-Azzawy M, El-Dawa A, Elsaid A, Mustafa W, Saad M . Association study between genetic polymorphisms in MTHFR and stroke susceptibility in Egyptian population: a case-control study. Sci Rep. 2024; 14(1):114. PMC: 10762080. DOI: 10.1038/s41598-023-50277-z. View

16.

Alamri A, Almuaigel M, Azra Z, AlShamrani F, AlMohish N, AlSheikh M . Clinical presentations, radiological characteristics, and biological risk factors of cerebral venous thrombosis at a University Hospital in Saudi Arabia. Saudi Med J. 2021; 42(2):213-218. PMC: 7989276. DOI: 10.15537/smj.2021.2.25667. View

17.

Elbadry M, Tawfeek A, Abdellatif M, Salama E, Abudeif A, Mahmoud H . Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia. Br J Haematol. 2021; 196(4):902-922. DOI: 10.1111/bjh.17986. View

18.

Alkhiary W, Azzam H, Yossof M, Aref S, Othman M, El-Sharawy S . Association of Hemostatic Gene Polymorphisms With Early-Onset Ischemic Heart Disease in Egyptian Patients. Clin Appl Thromb Hemost. 2015; 22(6):535-42. DOI: 10.1177/1076029615572466. View

19.

Ortel T, Neumann I, Ageno W, Beyth R, Clark N, Cuker A . American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020; 4(19):4693-4738. PMC: 7556153. DOI: 10.1182/bloodadvances.2020001830. View

20.

Connors J . Thrombophilia Testing and Venous Thrombosis. N Engl J Med. 2017; 377(12):1177-1187. DOI: 10.1056/NEJMra1700365. View